Lead poisoning causes lasting damage to the brain, heart, kidneys, and reproductive system, even at exposure levels once considered safe. Blood lead levels below 5 micrograms per deciliter are now linked to measurable harm in both children and adults. Globally, lead exposure was attributed to more than 1.5 million deaths in 2021, the vast majority from cardiovascular disease. The effects are not just acute: lead embeds itself in bone, where it can linger for decades and re-enter the bloodstream long after the original exposure ends.
How Lead Stays in Your Body for Decades
Once absorbed, lead doesn’t simply pass through. It initially circulates in the blood, but over time it migrates into bone tissue, where it behaves much like calcium and gets incorporated into the mineral structure. The body stores lead in two types of bone. In spongy bone (found in the pelvis, ribs, and skull), lead has a half-life of roughly 3 to 5 years. In dense cortical bone (the thick shafts of the legs and arms), the half-life stretches to about 30 years.
This matters because those bone stores aren’t permanent vaults. Any process that pulls calcium from bone also pulls lead back into the bloodstream. Pregnancy is the most well-documented trigger: the growing fetus demands calcium, and the mother’s skeleton responds by releasing stored minerals, lead included. The same remobilization happens during breastfeeding, menopause, and the gradual bone loss that comes with aging. Someone exposed to lead as a child or young adult can experience a second wave of internal exposure decades later without any new contact with lead.
Lasting Brain and Cognitive Effects
The brain is lead’s most studied target, and the damage is measurable well into adulthood. In a landmark study that followed children from birth to age 38, every 5-microgram-per-deciliter increase in childhood blood lead was associated with a 1.6-point drop in adult IQ after adjusting for the mother’s IQ, the child’s original IQ, and family income. The same increase corresponded to a 2-point reduction in perceptual reasoning and a 1.3-point loss in working memory. Those numbers may sound small on an individual level, but across a population they shift the entire bell curve downward.
Lead causes this damage by mimicking calcium at the molecular level. It slips through calcium channels in nerve cells and disrupts signaling at synapses, the junctions where neurons communicate. Specifically, it blocks the voltage-gated channels that neurons rely on to release chemical messengers, reducing the brain’s ability to transmit signals efficiently. This interference is especially destructive during childhood, when the brain is rapidly forming new connections, but it leaves a lasting imprint on adult cognition.
Behavioral and Mental Health Consequences
The effects extend well beyond IQ scores. The same Dunedin, New Zealand, birth cohort study found that higher childhood lead levels predicted greater overall mental health problems across the lifespan. For every 5-microgram-per-deciliter increase in childhood blood lead, participants scored significantly higher on measures of general psychopathology at age 38, with the strongest links to internalizing symptoms (anxiety and depression) and thought disorders.
Personality was affected too. Greater childhood exposure predicted higher neuroticism, lower agreeableness, and lower conscientiousness in adulthood. A separate cohort of lead-exposed children in Cincinnati showed that young adults with higher childhood blood lead scored higher on measures of impulsivity, egocentricity, and psychopathic traits. Researchers have proposed that lead’s disruption of emotion regulation helps explain the well-documented links between childhood lead exposure and adolescent delinquency, criminal arrests, and substance abuse problems. A study using linked health records found a twofold increased risk of schizophrenia spectrum disorder in adults who had blood lead levels above roughly 15 micrograms per deciliter as children.
Cardiovascular Disease and Early Death
Heart disease is the single largest driver of lead-related mortality worldwide. Adults with blood lead in the highest third of the population (at or above 3.62 micrograms per deciliter, a level many people would assume is harmless) had a 55% higher rate of cardiovascular death compared to those in the lowest third. When researchers compared people at the 90th percentile of blood lead to those at the 10th percentile, the risk of dying from cardiovascular disease was 70% higher.
Even moderately elevated levels carry risk. Adults with blood lead between 20 and 29 micrograms per deciliter had a 39% increase in circulatory mortality compared to those under 10. Lead promotes cardiovascular damage through several pathways: it increases oxidative stress in blood vessel walls, stiffens arteries, and raises blood pressure over time. These aren’t short-term effects that resolve once exposure stops. The cumulative burden stored in bone continues to feed low-level lead into the bloodstream for years.
Kidney Damage
The kidneys filter blood continuously, which makes them particularly vulnerable to circulating lead. Chronic low-level exposure is now recognized as an independent risk factor for chronic kidney disease. Blood lead levels as low as 1.5 micrograms per deciliter have been associated with reduced kidney function in adolescents, and doubling the blood lead level is linked to a significant drop in the kidneys’ filtration rate.
Repeated or sustained exposure creates a pattern of toxic stress on kidney tissue. Over time, this can progress to lead nephropathy, a form of chronic damage characterized by scarring in the kidney’s filtering structures. Once established, this damage is largely irreversible. People with lead nephropathy also tend to excrete less uric acid than expected, which can contribute to gout. The latent nature of this damage is important: someone exposed to lead in childhood may not show signs of kidney trouble until adulthood, when the slow accumulation of damage finally crosses a clinical threshold.
Reproductive and Fertility Effects
Lead disrupts reproductive health in both men and women. In men, it alters hormone levels and damages sperm quality, reducing fertility. In women, exposure before or during pregnancy increases the risk of miscarriage, stillbirth, and birth defects. The bone remobilization mechanism makes this especially concerning: a woman who was exposed to lead years or decades earlier can release stored lead into her bloodstream during pregnancy, exposing the developing fetus even if she has had no recent contact with lead sources.
Lead also passes into breast milk. A nursing infant absorbs the lead, which can interfere with brain development during the most sensitive period of neural growth. This creates a potential cycle where a mother’s historical exposure becomes her child’s current exposure.
Can the Damage Be Reversed?
The honest answer is: partially, and it depends on when treatment happens. Chelation therapy, which uses drugs that bind to lead so the body can excrete it, is the standard medical intervention for high blood lead levels. Animal research has shown that chelation can meaningfully improve learning, attention, and arousal regulation after lead exposure, suggesting that some cognitive recovery is possible. The improvements varied depending on how severe the exposure was and which specific brain functions were measured.
But chelation has important limitations. It primarily removes lead circulating in the blood and soft tissues. It is far less effective at pulling lead out of bone, where the largest reserves sit. And the neurological damage that has already occurred, particularly structural changes to developing brains in childhood, does not fully reverse even after lead levels drop. The CDC’s current blood lead reference value for children is 3.5 micrograms per deciliter, the threshold at which follow-up testing and possible intervention are recommended. The goal is to catch exposure early and stop it, because prevention consistently outperforms treatment in terms of long-term outcomes.
One notable caution from research: chelation drugs given to animals that were never exposed to lead actually caused lasting cognitive and emotional problems comparable to lead poisoning itself. This reinforces that chelation is a targeted treatment for confirmed lead burden, not a general detox strategy.